How should I reconstitute a Botox (onabotulinumtoxinA) vial with 2.5 mL preservative‑free saline and dose it using a 1 mL insulin syringe graduated in 10‑unit (0.01 mL) increments?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Botox Reconstitution with 2.5 mL Saline Using 1 mL Insulin Syringe

When reconstituting a 100-unit Botox vial with 2.5 mL preservative-free saline, you achieve a concentration of 4 units per 0.1 mL (or 4 units per 10 markings on your insulin syringe), making dosing straightforward: each 10-unit increment on the syringe equals 4 units of Botox.

Reconstitution Protocol

  • Draw up exactly 2.5 mL of preservative-free 0.9% sodium chloride into a standard syringe
  • Inject the saline slowly into the 100-unit Botox vial along the inside wall (not directly onto the powder) to minimize foaming
  • Gently rotate the vial—do not shake—to ensure complete dissolution
  • The final concentration is 4 units Botox per 0.1 mL 1

Dosing with Your 1 mL Insulin Syringe

Your insulin syringe has markings in 10-unit increments (each representing 0.01 mL). With the 2.5 mL dilution:

  • 10 units on syringe = 0.1 mL = 4 units of Botox
  • 25 units on syringe = 0.25 mL = 10 units of Botox
  • 50 units on syringe = 0.5 mL = 20 units of Botox
  • 100 units on syringe (full 1 mL) = 40 units of Botox

Critical Syringe Selection Advantage

Use insulin syringes with attached needles (low-dead-space) rather than tuberculin syringes with detachable needles. Research demonstrates that tuberculin syringes with detachable needles waste approximately 0.05 mL (2 units of Botox) per injection in the hub dead space, while insulin syringes with attached needles eliminate this waste entirely 1. Over time, this represents substantial product and cost savings without compromising patient outcomes.

Storage Considerations

Traditional FDA guidance recommends discarding reconstituted Botox after 4 hours when stored refrigerated 2. However, real-world practice data from dermatologic surgery shows that 68.6% of experienced physicians safely store reconstituted Botox for more than 1 week under refrigeration (2-8°C) and use single vials for multiple patients without any documented infections when standard sterile technique is maintained 3.

The key caveat: If you choose extended storage beyond 4 hours, you must:

  • Maintain strict sterile technique during initial reconstitution and all subsequent withdrawals
  • Store at 2-8°C continuously
  • Use single-dose withdrawal technique (never re-enter with a used needle)
  • Label the vial with reconstitution date and time

Preservative-Free vs. Preserved Saline

While the standard recommendation is preservative-free saline 2, one randomized trial in chronic migraine patients found that bacteriostatic (preserved) saline significantly reduced injection site pain compared to preservative-free saline (pain score 3.2 vs 5.3) without affecting efficacy or post-procedural headache frequency 4. This may be particularly relevant for patients with scalp allodynia or high sensitivity to injection discomfort, though preservative-free remains the conventional standard.

Common Pitfalls to Avoid

  • Do not shake the vial—this denatures the protein and reduces efficacy
  • Do not use tuberculin syringes with detachable needles—you'll waste 2 units per injection 1
  • Do not draw up air bubbles—these displace actual product volume and lead to underdosing
  • Do not reconstitute with volumes other than specified—this changes your concentration and increases dosing errors

References

Research

Proper dose, preparation, and storage of botulinum neurotoxin serotype A.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.